Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biotechnology company developing new medicines ...
Rebecca Wilkes is an ORNL synthetic biologist who conducts research for the University of Tennessee-Oak Ridge Innovation ...
Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the "Company"), a development-stage biotechnology company developing new medicines to treat pain and neuropathy ...
As Kerala moves quickly towards the 2026 Assembly elections - more quickly than anyone expected, since the Election ...
Achieved over $50 million of cash receipts, including $33.6 million in royalties and $16.9 million milestones, in full year 2025 • Total receipts increased 9% with royalties up ...
The ability to mass-produce sustainable materials from thin air sounds like a fantasy pitch. Yet the prospect is now a ...
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced it has ...
Baylor selects the Nautilus Voyager™ Platform, now available through Early Access Program, for development of a first-in-class computational multi-omics toolkit• NIH-funded project leverages ...
Achieved over $50 million of cash receipts, including $33.6 million in royalties and $16.9 million milestones, in full ...
Intermediate-scale benchtop bioreactor protocol streamlines production of iPSC-derived macrophages for research, drug discovery, and modeling.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results